PBH

Prestige Consumer Healthcare Inc. (PBH) | Rumor.io

Prestige Consumer Healthcare

PBH

Attention (50-day avg)0%

Attention rank (50-day avg)#3,854

Bullish sentiment (50-day avg)10%

Price to earnings ratio13.1

Market capitalization2.2B

Earnings per share3.57

Dividend yield (TTM)—

Revenue (annual)1.1B

Net income (annual)190.3M

Social

What share of all stock conversation is about PBH?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Jun 4

Prestige Consumer Healthcare Inc. (PBH) may experience share price movement if it continues to gain market share against prestige brands.
e.l.f. Beauty (ELF) maintains high gross margins due to sourcing 75% of production from China, but relocating the supply chain to avoid tariffs could increase costs and compress margins.
A normalized multiple of 16x for ELF at $52 price point is pricing in a smooth transition of tariff costs, which rarely happens in consumer discretionary.

Generated by AI

Sentiment

Of the messages about PBH that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	88.76% +15.42
Bearish	—	—	—	11.24% -15.42

Aug 28

$PBH has shown unusual strength, holding its morning gap and setting up for a potential blow-off move.
The company's recent announcement of a 5-year agreement with NBC Sports for its US subsidiary has led to a 60% surge in the stock's price.
$PBH has been executing on its plan, with the company's share price increasing from $1.00 in March to $12.50 last, making it a potentially lucrative investment opportunity.

Generated by AI

Topics

Of the messages about PBH that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	—	45.28%
Earnings	—	—	—	8.18%
Analysts	—	—	—	20.75%
Controversies	—	—	—	0%
Macro	—	—	—	25.79%
Technical Analysis	—	—	—	0%

Earnings· Nov 1

Prestige Consumer Healthcare ($PBH) reports FQ2 earnings of 65c EPS and $239.36M Revs, beating Estimize EPS consensus by 1c and Revenue consensus by $0.17M.
$PBH releases FY19 earnings guidance, with no specific details provided.
$PBH beats Estimize EPS consensus by 1c and Revenue consensus by $0.17M, with reported earnings of 65c EPS.

Announcements· Feb 10

Prestige Consumer Healthcare Inc. ($PBH) has signed a multi-year sports betting and marketing partnership with the National Hockey League (NHL).
$PBH has upsized and priced a $600 million senior notes offering, with the funds to be used for general corporate purposes.
Prestige Consumer Healthcare Inc. has announced the offering of $500 million senior notes, with the proceeds to be used for general corporate purposes.

Generated by AI

Community

Of the messages about PBH, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	39.05%
Newcomers	—	—	—	60.95%

Regulars· Feb 2

Prestige Consumer Healthcare Inc. reported Q3 2023 earnings that beat expectations, with EPS of $1.04 vs. $1.01 and revenue of $275.5M vs. $273.72M.
The company's Q3 2023 income statement will be published on February 2, and the earnings release was accompanied by a 8-K filing with the SEC.
Prestige Consumer Healthcare's FY23 guidance was lowered, with EPS and revenue expectations remaining in line.

Newcomers· Feb 7

New users are discussing PBH's stock price, with some looking for a potential buy opportunity based on its current price.
Others are focused on the MACD indicator, analyzing its position and potential implications for the stock's future performance.
A few users are sharing their observations about the stock's price movements, including its recent fluctuations and the reasons behind them.

Generated by AI

Prestige Consumer Healthcare has seen its share price under pressure over the past year, and that kind of slide naturally puts the spotlight on what investors are paying for its earnings today. The question now is whether the current valuation of Prestige Consumer Healthcare's profit stream still makes sense given how the business is executing. The stock has fallen 24.2% over the past year, which raises the issue of whether the current earnings multiple properly reflects what the company is...

15h agofinance.yahoo.com

Prestige Consumer Healthcare (PBH) Could Be 30% Undervalued After Its 2027 Targets

Prestige Consumer Healthcare (PBH) recently outlined medium term targets for fiscal 2027, putting fresh attention on its over the counter portfolio, free cash flow priorities, and the impact of Clear Eyes supply constraints. Prestige Consumer Healthcare’s recent medium term outlook lands after a tougher stretch in the market, with the share price down 23.34% year to date and the 1 year total shareholder return declining 24.25%, while the 30 day share price return has fallen 10.56%. This...

1d agoYahoo Finance

Prestige Consumer Healthcare Eyes Clear Eyes Recovery, $270M+ Free Cash Flow

Prestige Consumer Healthcare (NYSE:PBH) said its strategy centers on investing in established over-the-counter brands, maintaining a high-margin operating model and using free cash flow for debt reduction, acquisitions and other shareholder-value initiatives. Speaking at a fireside chat, Chief Fina

2d agoYahoo Finance

Prestige Consumer Healthcare at small-cap virtual conference: growth plan intact

5d agoInvesting.com

Prestige Consumer Healthcare at Barclays conference: growth via niche brands

19d agoInvesting.com

How InvestingPro Fair Value spotted Prestige Healthcare’s 43% drop By Investing.com

19d agoInvesting.com

Also Discussed

Investors talking about PBH also mention

#	Name	Attention
1	The Eastern CompanyEML	0%new
2	ZipRecruiter Inc.ZIP	0%0
3	Oppenheimer Holdings Inc.OPY	0%new
4	Phibro Animal Health Corporation Class A Common StockPAHC	0%0
5	Mesabi TrustMSB	0%new
6	Telos CorporationTLS	0%+0
7	CHN - The China Fund, Inc.	——
8	Carlisle Cos IncCSL	0%new
9	National HealthCare CorporationNHC	0%0
10	CenterspaceCSR	0%0

Prestige Consumer Healthcare Inc.

Healthcare
Drug Manufacturers - Specialty & Generic

Prestige Consumer Healthcare Inc. is a consumer healthcare company that develops, manufactures, markets, distributes, and sells branded over-the-counter health and personal care products. Prestige Consumer Healthcare Inc. focuses on everyday self-care categories such as pain relief, sore throat care, eye care, digestive health, skin protection, diaper rash treatment, ear wax removal, women’s care, and oral care. Its portfolio includes well-known products sold through mass merchandisers, drugstores, grocery retailers, dollar stores, convenience channels, club stores, and e-commerce outlets across North America, Australia, and other international markets. The company operates through North American OTC Healthcare and International OTC Healthcare segments, giving it broad exposure to consumer wellness products used for common, recurring health needs. Prestige Consumer Healthcare Inc. plays a specialized role in the market as a branded over-the-counter healthcare provider with a portfolio centered on established consumer brands.

Website

Location

660 White Plains Road

Tarrytown, NY, 10591

United States

Social

What share of all stock conversation is about PBH?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Jun 4

Prestige Consumer Healthcare Inc. (PBH) may experience share price movement if it continues to gain market share against prestige brands.
e.l.f. Beauty (ELF) maintains high gross margins due to sourcing 75% of production from China, but relocating the supply chain to avoid tariffs could increase costs and compress margins.
A normalized multiple of 16x for ELF at $52 price point is pricing in a smooth transition of tariff costs, which rarely happens in consumer discretionary.

Generated by AI

Sentiment

Of the messages about PBH that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	88.76% +15.42
Bearish	—	—	—	11.24% -15.42

Aug 28

$PBH has shown unusual strength, holding its morning gap and setting up for a potential blow-off move.
The company's recent announcement of a 5-year agreement with NBC Sports for its US subsidiary has led to a 60% surge in the stock's price.
$PBH has been executing on its plan, with the company's share price increasing from $1.00 in March to $12.50 last, making it a potentially lucrative investment opportunity.

Generated by AI

Topics

Of the messages about PBH that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	—	45.28%
Earnings	—	—	—	8.18%
Analysts	—	—	—	20.75%
Controversies	—	—	—	0%
Macro	—	—	—	25.79%
Technical Analysis	—	—	—	0%

Earnings· Nov 1

Prestige Consumer Healthcare ($PBH) reports FQ2 earnings of 65c EPS and $239.36M Revs, beating Estimize EPS consensus by 1c and Revenue consensus by $0.17M.
$PBH releases FY19 earnings guidance, with no specific details provided.
$PBH beats Estimize EPS consensus by 1c and Revenue consensus by $0.17M, with reported earnings of 65c EPS.

Announcements· Feb 10

Prestige Consumer Healthcare Inc. ($PBH) has signed a multi-year sports betting and marketing partnership with the National Hockey League (NHL).
$PBH has upsized and priced a $600 million senior notes offering, with the funds to be used for general corporate purposes.
Prestige Consumer Healthcare Inc. has announced the offering of $500 million senior notes, with the proceeds to be used for general corporate purposes.

Generated by AI

Community

Of the messages about PBH, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	39.05%
Newcomers	—	—	—	60.95%

Regulars· Feb 2

Prestige Consumer Healthcare Inc. reported Q3 2023 earnings that beat expectations, with EPS of $1.04 vs. $1.01 and revenue of $275.5M vs. $273.72M.
The company's Q3 2023 income statement will be published on February 2, and the earnings release was accompanied by a 8-K filing with the SEC.
Prestige Consumer Healthcare's FY23 guidance was lowered, with EPS and revenue expectations remaining in line.

Newcomers· Feb 7

New users are discussing PBH's stock price, with some looking for a potential buy opportunity based on its current price.
Others are focused on the MACD indicator, analyzing its position and potential implications for the stock's future performance.
A few users are sharing their observations about the stock's price movements, including its recent fluctuations and the reasons behind them.

Generated by AI

Prestige Consumer Healthcare

Social

Jun 4

Sentiment

Aug 28

Topics

Earnings· Nov 1

Announcements· Feb 10

Community

Regulars· Feb 2

Newcomers· Feb 7

News

Has Prestige Consumer Healthcare (PBH) Fallen Far Enough On Earnings?

Prestige Consumer Healthcare (PBH) Could Be 30% Undervalued After Its 2027 Targets

Prestige Consumer Healthcare Eyes Clear Eyes Recovery, $270M+ Free Cash Flow

Prestige Consumer Healthcare at small-cap virtual conference: growth plan intact

Prestige Consumer Healthcare at Barclays conference: growth via niche brands

How InvestingPro Fair Value spotted Prestige Healthcare’s 43% drop By Investing.com

Also Discussed

Prestige Consumer Healthcare Inc.

Company Information

Location

News

Has Prestige Consumer Healthcare (PBH) Fallen Far Enough On Earnings?

Prestige Consumer Healthcare (PBH) Could Be 30% Undervalued After Its 2027 Targets

Prestige Consumer Healthcare Eyes Clear Eyes Recovery, $270M+ Free Cash Flow

Prestige Consumer Healthcare at small-cap virtual conference: growth plan intact

Prestige Consumer Healthcare at Barclays conference: growth via niche brands

How InvestingPro Fair Value spotted Prestige Healthcare’s 43% drop By Investing.com

Also Discussed

Social

Jun 4

Sentiment

Aug 28

Topics

Earnings· Nov 1

Announcements· Feb 10

Community

Regulars· Feb 2

Newcomers· Feb 7